ImmediapressEVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture Di Redazione - 18 Ottobre 2019 CondividiFacebook Twitter WhatsApp Linkedin Email Print Telegram